The Company has 787,855,052 ordinary fully paid shares in issue.
The number of ordinary shares not in public hands amounts to 6,956,691 equivalent to 0.9% of the issued allotted and fully paid ordinary shares.
This is correct as of 20 March 2023
|
Share Options |
|||
|
Exercise price (£) |
Number of share options exercisable into ordinary shares on issue | Expiry Date | Share options as a % of issued shares |
|
0.30 0.27 0.33 0.671 |
4,825,000 7,000,000 12,430,000 21,705,000 |
30 September 2024 6 July 2030 27 January 2031 18 January 2027 |
0.62% 0.90% 1.60% 2.80% |
|
Share Warrants(1) |
|||
|
Exercise price (£) |
Number of share warrants exercisable into non-voting shares | Expiry date | Share options as a % of issued shares |
| 0.30 | 4,803,921 | 30 September 2024 | 1.29% |
Note:
(1) The share options are exercisable into ordinary shares upon exercise, whereas the warrants are convertible on a 1:1 basis into non-voting shares upon exercise. Non voting shares are further convertible into ordinary shares on a 1:1 basis.
The Ordinary Shares of the Company have not been nor will they be registered under the United States Securities Act of 1933, as amended ("Securities Act"), or under the securities laws of any state of the United States or under the applicable securities laws of Australia, the Republic of South Africa, the Republic of Ireland, Japan or Canada. Accordingly, subject to certain exceptions, the Ordinary Shares may not, directly or indirectly, be offered, sold, transferred, taken up or delivered, directly or indirectly, in the United States, Australia, the Republic of South Africa, the Republic of Ireland, Japan or Canada or for the benefit of any US person (as defined in Regulation S under the Securities Act).